The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Midol
ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE · ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 · Tablet · Oral · Navajo Manufacturing Company Inc.
NDC 67751-0145-01 · 2 POUCH in 1 CARTON / 2 TABLET in 1 POUCH · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M013
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ACETAMINOPHEN, CAFFEINE, and PYRILAMINE MALEATE (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Lil' Drug Store Products, Inc | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Acme United Corporation | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bayer HealthCare LLC. | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bayer HealthCare LLC. | ACETAMINOPHEN 500 mg/1; PAMABROM 25 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Navajo Manufacturing Company Inc. | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| R J General Corporation | PYRILAMINE MALEATE 15 mg/1; ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| Select Consumer Group | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| R J General Corporation | PYRILAMINE MALEATE 500 mg/1; ACETAMINOPHEN 60 mg/1; CAFFEINE 15 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| R J General Corporation | ACETAMINOPHEN 500 mg/1; CAFFEINE 60 mg/1; PYRILAMINE MALEATE 15 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Midol — NDC 67751-0145-01," retrieved September 3, 2026, https://drugdashboards.com/drug/67751014501.
Free to cite with attribution — see how the data is put together.